BEAM

Beam Therapeutics Inc.NASDAQHealthcare

$24.66+1.82%ClosedMarket Cap: $2.51B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-26	Citigroup	—	Buy	—
2026-02-25	RBC Capital	—	Sector Perform	—
2026-02-25	Wedbush	—	Outperform	—
2026-01-21	Bernstein	—	Outperform	—
2025-10-10	HC Wainwright & Co.	—	Buy	—
2025-10-09	JP Morgan	—	Overweight	—
2025-08-06	Barclays	—	Equal Weight	—
2025-05-07	Guggenheim	—	Buy	—
2025-05-07	Barclays	—	Equal Weight	—
2025-05-07	Wells Fargo	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-4.51	$59.5M	12
Sun Dec 31	$-4.53	$116.3M	11
Mon Dec 31	$-3.13	$399.5M	4
Tue Dec 31	$-1.11	$712.0M	4